木月皿2015-12-07 06:42
回复@踏血寻踪: 谢谢你的分析。乙肝的试验应该是最值得关注的,那一例面瘫导致了股价的一蹶不振。虽然谈数据还为时太早,但公司能重启乙肝试验就意味着这个药还有希望。明年1月份的两项2期数据是比较被忽略的,即使阳性也有可能股价飙升一下再回落。所以在现阶段$TETRALOGIC PHARMACEUTICALS(TLOG)...查看全文
wfan20222015-07-17 18:16
$TETRALOGIC PHARMACEUTICALS(TLOG)$ PNAS重大成果:乙肝治愈现曙光
2015-04-21 来源 佚名
澳大利亚的科学家们发现了一种针对乙型肝炎病毒(HBV)感染的潜在治愈方法,在临床前模型中这种有前景的新疗法100%成功消除了感染。
现在澳大利亚的一些患者在墨尔本、珀斯和阿德莱德开展的1/2a期...查看全文
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-16 AccNo: 0001558370-16-004186 Size: 10 MB 网页链接
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 8-K - Current report Filed: 2016-02-26 AccNo: 0001157523-16-004753 Size: 15 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$TETRALOGIC PHARMACEUTICALS(TLOG)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0001571049-16-011807 Size: 109 KB 网页链接
$TETRALOGIC PHARMACEUTICALS(TLOG)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-10 AccNo: 0000919574-16-010036 Size: 92 KB 网页链接
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-02-05,10% Owner,Clarus Lifesciences II, L.P. ,卖出,832881普通股, $0.20
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-02-04,10% Owner,Clarus Lifesciences II, L.P. ,卖出,500026普通股, $0.14
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-02-03,10% Owner,Clarus Lifesciences II, L.P. ,卖出,82583普通股, $0.15
$TETRALOGIC PHARMACEUTICALS(TLOG)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-02-05 AccNo: 0001104659-16-094208 Size: 223 KB 网页链接
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 8-K - Current report Filed: 2016-02-03 AccNo: 0001104659-16-093483 Size: 18 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http:/...
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-02-02,10% Owner,Clarus Lifesciences II, L.P. ,卖出,176306普通股, $0.17